Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.410
-0.070 (-2.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $198.94 million as of November 21, 2024. Its market cap has decreased by -70.69% in one year.
Market Cap
198.94M
Enterprise Value
-27.66M
1-Year Change
-70.69%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $198.94M, a decrease of -69.38%. That is a compound annual growth rate of -12.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 204.70M | -75.26% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 217.36M |
| Trevi Therapeutics | 216.76M |
| Cybin | 215.74M |
| Molecular Partners AG | 214.31M |
| Zura Bio | 209.59M |
| High Tide | 207.33M |
| ADC Therapeutics | 206.92M |
| Sera Prognostics | 205.34M |